Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib plus Pravastatin in Advanced Hepatocarcinoma
NCT01418729Phase 2Completed
- Sponsor
- Hospital Universitario Donostia
- Start
- Sep 2011
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pravastatin in hepatocellular carcinoma (HCC), sponsored by Hospital Universitario Donostia. Started Sep 2011; status: completed.
02
Drugs
pravastatin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01418729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01418729.